ALUR
Allurion Technologies, Inc.
NYSE: ALUR · HEALTHCARE · MEDICAL DEVICES
$0.74
-0.03% today
Updated 2026-04-29
Market cap
$8.96M
P/E ratio
—
P/S ratio
0.52x
EPS (TTM)
$-16.20
Dividend yield
—
52W range
$0 – $4
Volume
3.2M
Allurion Technologies, Inc. (ALUR) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Operating cash flow | $-35.00 | $-14.33M | $-46.98M | $-63.98M | $-42.30M |
| Capital expenditures | $5.00 | $912000.00 | $1.55M | $1.61M | $611000.00 |
| Depreciation | — | — | — | — | — |
| Stock-based comp | — | $313000.00 | $437000.00 | $8.36M | $3.06M |
| Free cash flow | $-40.00 | $-15.24M | $-48.53M | $-65.59M | $-42.91M |
| Investing cash flow | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — |
| Dividends paid | — | — | $132000.00 | — | — |
| Share repurchases | — | — | — | — | — |
| Debt repayment | — | — | — | — | — |
| Net change in cash | — | — | — | — | — |